The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
you know i'm considered inoperable but we know that having this primary tumor here increases my risk for mutations okay remember i said that the tyrosine kinase inhibitors or the tkis they work amazingly well but only so long
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
having this primary tumor here increases my risk for mutations okay remember i said that the tyrosine kinase inhibitors or the tkis they work amazingly well but only so long you know somewhere between eight and say you know on average eight and with the more um advanced ones you know at the long end is like you know 24 to 30 months okay um so that's not enough time that doesn't get me to 11.